Skip to main content

Table 5 Correlation of clinical outcome with breast subtypes

From: Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study

 

ERBB2+

Triple-negative

Luminal

 

DTC in bone marrow

    

   no

5 (71%)

15 (79%)

61 (78%)

ns

   yes

2 (29%)

5 (21%)

4 (22%)

ns

Disease-free

    

   no

2 (29%)

4 (21%)

2 (3%)

p = 0.001

   yes

5 (71%)

15 (79%)

76 (97%)

 
  1. Abbreviations: DTC, disseminated tumor cells; ns, nonsignificant